Updates are available Correction dated 2017-03-27
Click to view Correction: https://doi.org/10.1007/s00467-017-3653-0
-
Authors
Crawford, Brendan D.
Gillies, Christopher E.
Robertson, Catherine C.
Kretzler, Matthias
Otto, Edgar
Vega-Wagner, Virginia
Sampson, Matthew G.
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (RO1DK108805, T32DK007378)
Charles Woodson Clinical Research Fund
- License Information
-
More Information
Article History
Received: 6 July 2016
Revised: 25 August 2016
Accepted: 29 August 2016
First Online: 20 October 2016
Compliance with ethical standards
:
: The Nephrotic Syndrome Study Network Consortium (NEPTUNE), U54-DK-083912, is a part of the National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN), supported through a collaboration between the Office of Rare Diseases Research (ORDR), NCATS, and the National Institute of Diabetes, Digestive, and Kidney Diseases. Additional funding and/or programmatic support for this project has also been provided by the University of Michigan, the NephCure Kidney International, and the Halpin Foundation.
: Brendan Crawford is supported by the National Institutes of Health Kidney Research Training Grant T32DK007378. Matthew Sampson is supported by the Charles Woodson Clinical Research Fund, RO1DK108805, and is a Carl W. Gottschalk Research Scholar of ASN Foundation for Kidney Research.
